Hallucinogen actions on 5-HT receptors reveal distinct mechanisms of activation and signalling by G protein-coupled receptors

AAPS Journal

Volumn 7, Issue 4, 2006, Pages

  Weinstein, Harel ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Bioinformatics tools; Mathematical modeling; Membrane proteins; Molecular dynamics simulations; Molecular modeling; Signaling

Indexed keywords

G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PSYCHEDELIC AGENT; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN RECEPTOR;

BIOINFORMATICS; CELL COMPARTMENTALIZATION; CELL FUNCTION; COMPARATIVE STUDY; DRUG ABUSE; HUMAN; LIGAND BINDING; MATHEMATICAL MODEL; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; MOLECULAR MODEL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN MOTIF; QUANTITATIVE ANALYSIS; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CHEMICAL STRUCTURE; DRUG EFFECT; METABOLISM; PHYSIOLOGY;

ANIMALS; HALLUCINOGENS; HUMANS; MODELS, MOLECULAR; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, SEROTONIN; SIGNAL TRANSDUCTION;

EID: 33747124117     PISSN: 15221059     EISSN: 15221059     Source Type: Journal    
DOI: 10.1208/aapsj070485     Document Type: Review

References (99)

1. Nichols DE. Hallucinogens. Pharmacol Ther. 2004;101:131-181.
2. Gresch PJ, Strickland LV, Sanders-Bush E. Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors. Neuroscience. 2002;114:707-713.
3. Aghajanian GK, Marek GJ. Serotonin and hallucinogens. Neuropsychopharmacology. 1999;21:16S-23S.
4. Visiers I, Ballesteros JA, Weinstein H. Three-dimensional representations of G protein-coupled receptor structures and mechanisms, Methods Enzymol. 2002;343:329-371.
5. Filizola M, Visiers I, Skrabanek L, Campagne F, Weinstein H. Functional mechanisms of GPCRs in a structural context. In: Schousboe A, Bráuner-Osborne H, eds, Strategies in Molecular Neuropharmacology. Totowa, NJ: Humana Press; 2003.235-266.
6. Filizola M, Weinstein H. The study of G-protein coupled receptor oligomerization with computational modeling and bioinformatics. FEBS J. In press.
7. Filizola M, Weinstein H. Structural models for dimerization of G-protein coupled receptors: the opioid receptor homodimers. Biopolymers. 2002;66:317-325.
8. Filizola M, Guo W, Javitch JA, Weinstein H. Oligomerization domains in G-protein coupled receptors: insights into the structural basis of GPCR association. In: Devi LA, ed. The G-Protein Coupled Receptor Handbook. Totowa, NJ, Humana Press Inc; 2005.
9. Beuming T, Skrabanek L, Niv MY, Mukherjee P, Weinstein H. PDZBase: a protein-protein interaction database for PDZ-domains. Bioinformatics. 2005;21:827-828.
10. Chang CW, Hassan SA, Weinstein H. Determinants for specificity in binding to the PDZ domain of PICKI. Biophys J. 2004;86:96a.
11. Madsen KL, Beuming T, Niv MY, et al. Molecular determinants for the complex binding specificity of the PDZ domain in pick 1. J Biol Chem. 2005;280:20539-20548.
12. Slepchenko BM, Schaff JC, Macara I, Loew LM. Quantitative cell biology with the Virtual Cell. Trends Cell Biol. 2003; 13:570-576.
13. Slepchenko BM, Schaff JC, Carson JH, Loew LM. Computational cell biology: spatiotemporal simulation of cellular events. Annu Rev Biophys Biomol Struct. 2002;31:423-441.
14. Wachman ES, Poage RE, Stiles JR, Farkas DL, Meriney SD. Spatial distribution of calcium entry evoked by single action potentials within the presynaptic active zone. J Neurosci. 2004;24:2877-2885.
15. Campagne F, Neves S, Chang CW, et al. Quantitative information management for the biochemical computation of cellular networks. Sci STKE. 2004;2004:p111.
16. Ebersole BJ, Visiers I, Weinstein H, Sealfon SC. Molecular basis of partial agonism: orientation of indoleamine ligands in the binding pocket of the human 5-HT2A serotonin receptor determines relative efficacy. Mol Pharmacol. 2003;63:36-43.
17. Visiers I, Ebersole BJ, Dracheva S, Ballesteros JA, Sealfon SC, Weinstein H. Structural motifs as functional microdomains in G-protein-coupled receptors: energetic considerations in the mechanism of activation of the serotonin 5-HT2A receptor by disruption of the ionic lock of the arginine cage. Int J Quantum Chem. 2002;88.65-75.
18. Prioleau C, Visiers I, Ebersole BJ, Weinstein H, Sealfon SC. Conserved helix 7 tyrosine acts as a multistate conformational switch in the 5HT2C receptor: identification of a novel "locked-on" phenotype and double revertant mutations. J Biol Chem. 2002;277-36577-36584.
19. Gonzalez-Maeso J, Yuen T, Ebersole BJ, et al. Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex. J Neurosci. 2003;23:8836-8843.
20. Gingrich JA, Ansorge MS, Merker R, Weisstaub N, Zhou M. New lessons from knockout mice. the role of serotonin during development and its possible contribution to the origins of neuropsychiatric disorders. CNS Spedr. 2003;8:572-577.
21. Ebersole BJ, Sealfon SC. Strategies for Mapping the Binding Site of the Serotonin 5HT2A Receptor. In: Iyengar R, Hildebrandt J, eds. Methods in Enzymology. San Diego, CA: Academic Press; 2001.
22. Beuming T, Weinstein H. A knowledge-based scale for the analysis and prediction of buried and exposed faces of transmembrane domain proteins. Bioinformatics. 2004;20.1822-1835.
23. Ebersole BJ, Visiers I, Weinstein H, Sealfon SC. Molecular basis of partial agonism: orientation of indoleamine ligands in the binding pocket of the human serotonin 5-HT2A receptor determines relative efficacy. Mol Pharmacol. 2003;63:36-43.
24. Ballesteros J, Kitanovic S, Guamieri F, et al. Functional microdomains In G-protein-coupled receptors: the conserved arginine-cage motif in the gonadotropin-releasing hormone receptor. J Biol Chem. 1998;273:10445-10453.
25. Javitch JA. The ants go marching 2 by 2: oligomeric structure of G-protein-coupled receptors. Mol Pharmacol. 2004;66:1077-1082.
26. Filizola M, Olmea O, Weinstein H. Prediction of heterodimerization interfaces of G-protein coupled receptors with a new subtractive correlated mutation method. Protein Eng. 2002;15:881-885.
27. Filipek S, Teller DC, Palczewski K, Stenkamp R. The crystallographic model of rhodopsin and its use in studies of other G protein-coupled receptors. Annu Rev Biophys Biomol Struct. 2003;32:375-397.
28. Filipek S, Krzysko KA, Fotiadis D, et al. A concept for G protein activation by G protein-coupled receptor dimers: the transducin/ rhodopsin interface. Photochem Photobiol Sci. 2004;3:628-638.
29. Hoffmann C, Galetta G, Bunemann M, et al. A FIAsH-based FRET approach to determine G protein-coupled receptor activation in living cells. Nat Methods. 2005;2:171-176.
30. Zhuang X, Masson J, Gingrich JA, Rayport S, Hen R. Targeted gene expression in dopamine and serotonin neurons of the mouse brain. J Neurosci Methods. 2005; 143:27-32.
31. Ballesteros JA, Shi L, Javitch JA. Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. Mol Pharmacol. 2001;60:1-19.
32. Huang P, Li J, Chen C, Visiers L, Weinstein H, Liu-Chen LY. Functional role of a conserved motif in TM6 of the rat mu opioid receptor: constitutively active and inactive receptors result from substitutions of Thr6.34 (279) with Lys and Asp. Biochemistry. 2001;40:13501-13509.
33. Flanagan CA, Zhou W, Chi L, et al. The functional microdomain in transmembrane helices 2 and 7 regulates expression, activation, and coupling pathways of the gonadotropin- releasing hormone receptor. J Biol Chem. 1999;274.28880-28886.
34. Xu W, Ozdener F, Li JG, et al. Functional role of the spatial proximity of Asp2.50(114) in TMH2 and Asn7.49(332) in TMH7 of the m oploid receptor. FEBS Left. 1999;447:318-324.
35. Decaillot FM, Befort K, Filliol D, Yue S, Walker P, Kieffer BL. Opioid receptor random mutagenesis reveals a mechanism for G protein-coupled receptor activation. Nat Struct Bidt. 2003; 10:629-636.
36. Janz JM, Farrens DL. Rhodopsin activation exposes a key hydrophobic binding site for the transducin alpha-subunit C terminus. J Biol Chem. 2004;279:29767-29773.
37. Shapiro DA, Kristiansen K, Weiner DM, Kroeze WK, Roth BL. Evidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6. J Biol Chem. 2002;277:11441-11449.
38. Kroeze WK, Kristiansen K, Roth BL. Molecular biology of serotonin receptors structure and function at the molecular level. Curr Top Med Chem. 2002;2:507-528.
39. Meng EC, Bourne HR. Receptor activation: what does the rhodopsin structure tell us? Trends Pharmacol Sci. 2001;22:587-593.
40. Gerber BO, Meng EC, Dotsch V, Baranski TJ, Boume HR. An activation switch in the ligand binding pocket of the C5a receptor. J Biol Chem. 2001;276:3394-3400.
41. Ghanouni P, Steenhuis JJ, Farrens DL, Kobilka BK. Agonist-induced conformational changes in the G-protein-coupling domain of the beta 2 adrenergic receptor. Proc Natl Acad Sci USA. 2001;98:5997-6002.
42. Ballesteros JA, Jensen AD, Liapakis G, et al. Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J Biol Chem. 2001;276.29171-29177.
43. Gether U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev. 2000;21:90-113.
44. Gether U, Asmar F, Meinild AK, Rasmussen SG. Structural basis for activation of G-protein-coupled receptors. Pharmacol Toxicol. 2002;91:304-312.
45. Palczewski K, Kumasaka T, Hori T, et al. Crystal structure of rhodopsin: a G-protein coupled receptor. Science. 2000;289:739-745.
46. Okada T, Ernst OP, Palczewski K, Hofmann KP. Activation of rhodopsin: new insights from structural and biochemical studies. Trends Biochem Sci. 2001;26:318-324.
47. Stenkamp RE, Teller DC, Palczewski K. Crystal structure of rhodopsin: a G-protein-coupled receptor. ChemBioChem. 2002;3:963-967.
48. Filipek S, Stenkamp RE, Teller DC, Palczewski K. G protein-coupled receptor rhodopsin: a prospectus. Annu Rev Physiol,2003;65:851-879.
49. Fritze O, Filipek S, Kuksa V, Palczewski K, Hofmann KP, Ernst OP. Role of the conserved NPxxY(x) 5,6F motif in the rhodopsin ground state and during activation. Proc Natl Acad Sci USA. 2003:100:2290-2295.
50. Kalatskaya I, Schussler S, Blaukat A, et al. Mutation of tyrosine in the conserved NPXXY sequence leads to constitutive phosphorylation and internalization, but not signaling, of the human B2 bradykinin receptor. J Biol Chem. 2004;279:31268-31276.
51. Ballesteros JA, Weinstein H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. In: Sealfon SC, ed. Receptor Molecular Biology. San Diego, CA: Academic Press., 1995:366-428.
52. Lin SW, Sakmar TP. Specific tryptophan UV-absorbance changes are probes of the transition of rhodopsin to its active state. Biochemistry. 1996;35:11149-11159.
53. Shi L, Javitch JA. The second extracellular loop of the dopamine D2 receptor lines the binding-site crevice. Proc Natl Acad Sci USA. 2004; 101:440-445.
54. Singh R, Hurst DP, Barnett-Norris J, Lynch DL, Reggio PH, Guarnieri F. Activation of the cannabinoid CB1 receptor may involve a W6 48/F3 36 rotamer toggle switch. J Pept Res. 2002,60:357-370.
55. Shi L, Liapakis G, Xu R, Guamieri F, Ballesteros JA, Javitch JA. Beta2 adrenergic receptor activation: modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. J Biol Chem. 2002;277:40989-40996.
56. McAlister SD, Hurst DP,Barneft-Norris J, Lynch D, Reggio PH, Abood ME. Structural mimicry in class A GPCR rotamer toggle switches: the importance of the F3.36(201)/W6.48(357) interaction in cannabinoid CB1 receptor activation. J Biol Chem. 2004;279,48024-48037.
57. McAllister SD, Rizvi G, Anavi-Goffer S, et al. An aromatic microdomain at the cannabinoid CB(1) receptor constitutes an agonist/inverse agonist binding region. J Med Chem. 2003;46:5139-5152.
58. Gay EA, Urban JD, Nichols DE, Oxford GS, Mailman RB. Functional selectivity of D2 receptor ligands in a Chinese hamster ovarv hD2L cell line: evidence for induction of lioand-specific receotor states. Mol Pharmacol. 2004;66:97-105.
59. Mottola DM. Kilts JD, Lewis MM, et al. Functional selectivity of dopamine receptor agonists. 1. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase. J Pharmacol Exp Ther. 2002;301.1166-1178.
60. Ghanouni P, Gryczynski Z, Steenhuis JJ, et al. Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor. J Biol Chem. 2001;276:24433-24436.
61. McLaughlin JN, Shen L, Holinstat M, Brooks JD, Dibenedetto E, Hamm HE. Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1. J Biol Chem, 2005;280:25048-25059.
62. Vilardaga JP, Steinmeyer R, Harms GS, Lohse MJ. Molecular basis of inverse agonism in a G protein coupled receptor. Nature Chem Biol. 2005;1:25-28.
63. Javitch A Ballesteros JA, Weinstein H, Chen J. A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding site crevice. Biochemistry. 1998;37:998-1006.
64. Javitch JA, Ballesteros JA, Weinstein H, Chen J. A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice. Biochemistry. 1998;37:998-1006.
65. Filizola M, Hassan SA, Artoni A, Coller BS, Weinstein H. Mechanistic insights from a refined 3-dimensional model of integrin alphallbbeta3. J Biol Chem. 2004;279:24624-24630.
66. Liggett SB. Update on current concepts of the molecular basis of beta2-adrenergic receptor signaling. J Allergy Clin Immunol. 2002; 110:S223-S227.
67. McAllister SD, Hurst DP, Barnett-Norris J, Lynch D, Reggio PH, Abood ME. Structural mimicry in class A G protein-coupled receptor rotamer toggle switches: the importance of the F3.36(201)/W6.48(357) interaction in cannabinoid CB1 receptor activation. J Biol Chem. 2004,279:48024-48037.
68. Mehler EL, Periole X, Hassan SA, Weinstein H. Key issues in the computational simulation of GPCR function: representation of loop domains. J Comput Aided Mol Des. 2002;16:841-853.
69. Visiers I Hassan SA Weinstein H Differences in conformational properties of the second intracellular loop (IL2) in 5HT(2C) receptors modified by RNA editing can account for G protein coupling efficiency. Protein Eng. 2001;14:409-414.
70. McGrew L, Price RD, Hackler E, Chang MS, Sanders-Bush E. RNA editing of the human serotonin 5-HT2C receptor disrupts transactivation of the small G-protein RhoA. Mol Pharmacol. 2004;65:252-256.
71. Niswender CM, Copeland SC, Herrick-Davis K, Emeson RB, Sanders-Bush E. RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J Biol Chem. 1999;274:9472-9478.
72. Hassan SA, Mehler EL, Zhang D, Weinstein H. Molecular dynamics simulations of peptides and proteins with a continuum electrostatic model based on screened Coulomb potentials. Proteins. 2003;51:109-125.
73. Hassan SA, Mehler EL, Weinstein H. Structure calculations of protein segments connecting domains with defined secondary structure: a simulated annealing monte carlo combined with biased scaled collective variables technique. In: Hark K, Schlick T, eds. Lecture Notes in Computational Science and Engineering. New York, NY. Springer Verlag, Ag; 2002:197-231.
74. Sankararamakrishnan R, Weinstein H. Surface tension parameterization in molecular dynamics simulations of a phospholipid-bilayer membrane. calibration and effects. J Phys Chem B. 2004; 108:11802-11811.
75. Fong SL, Tsin AT, Bridges CD, Liou GI. Detergents for extraction of visual pigments, types, solubilization, and stability. Methods Enzymol. 1982;81:133-140.
76. Liang Y, Fotiadis D, Filipek S, Saperstein DA, Palczewski K, Engel A. Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J Biol Chem. 2003,278:21655-21662.
77. Sankararamakrishnan R, Weinstein H. Molecular dynamics simulations predict a tilted orientation for the helical region of dynorphin A(1-17) in dimyristoylphosphatidylcholine bilayers. Biophys J. 2000;79:2331-2344,
78. Sankararamakrishnan R, Weinstein H. Positioning and stabilization of dynorphin peptides in membrane bilayers: the mechanistic role of aromatic and basic residues revealed from comparative MD simulations. J Phys Chem B. 2002;106:209-218.
79. Tieleman DP, Berendsen HJ, Sansom MS. An alamethicin channel in a lipid bilayer:molecular dynamics simulations. Biophys J 1999;76:1757-1769.
80. Marrink SJ, Berger O, Tieleman P, Jahnig F. Adhesion forces of lipids in a phospholipid membrane studied by molecular dynamics simulations. Biophys J. 1998;74:931-943.
81. Petrache HI, Dodd SW, Brown MF. Area per lipid and acyl length distributions in fluid phosphatidylcholines determined by (2)H NMR spectroscopy. Biophys J. 2000;79:3172-3192.
82. Bock G, Goode JA, eds. In silico simulation of biological processes, Novartis Foundation Symposium 247. In: Novartis Foundation Symposium. Vol 247 Chichester, UK: John Wiley & Sons; 2002:262.
83. Fall C, Marland ES, Wagner JM, Tyson JJ. Computational Cell Biology. New York, NY: Springer Verlag; 2002.
84. Brown KS, Hill CC, Calero GA, et al. The statistical mechanics of complex signaling networks: nerve growth factor signaling. Phys Biol. 2004;1:184-195.
85. Barrios-Rodiles M, Brown KR, Ozdamar B, et al. High-throughput mapping of a dynamic signaling network in mammalian cells. Science. 2005;307:1621-1625.
86. Loew LM. The Virtual Cell project. Novartis Found Symp. 2002;247:151-160. Discussion 160-161, 198-206, 244-252.
87. Loew LM, Schaff JC. The Virtual Cell: a software environment for computational cell biology. Trends Biotechnol. 2001;19:401-406.
88. Sauro HM, Kholodenko BN, Quantitative analysis of signaling networks. Prog Biophys Mol Biol. 2004;86:5-43.
89. Kurrasch-Orbaugh DM, Parrish JC, Watts VJ, Nichols DE. A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: the involvement of MAP kinases. J Neurochem. 2003;86:980-991.
90. Kurrasch-Orbaugh DM, Watts VJ, Barker EL, Nichols DE. Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves. J Pharmacol Exp Ther. 2003;304:229-237.
91. Akin D, Manier DH, Sanders-Bush E, Shelton RC. Decreased serotonin 5-HT2A receptor-stimulated phosphoinositide signaling in fibroblasts from melancholic depressed patients. Neuropsychopharmacology. 2004;29:2081-2087.
92. Metabolism in cerebral cortex. Neuropharmacology. 1984;23:993-996.
93. Roth BL, Nakald T, Chuang DM, Costa E. Aortic recognition sites for serotonin (5HT) are coupled to phospholipase C and modulate phosphatidylinositol turnover. Neurophannacology. 1984;23:1223-1225.
94. Sanders-Bush E, Tsutsumi M, Burris KD. Serotonin receptors and phosphatidylinositol turnover. Ann N Y Acad Sci. 1990;600:224-235.
95. Berg KA, Maayani S, Goldfarb J, Scaramellini C, Leff P, Clarke WP. Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. Mol Pharmacol 1998;54:94-104.
96. Bhalla US, Ram PT, Iyengar R. MAP kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase signaling network. Science. 2002;297:1018-1023.
97. Weng G, Bhalla US, Iyengar R. Complexity in biological signaling systems. Science. 1999,284:92-96.
98. Bruggeman FJ, Kholodenko BN. Modular interaction strengths in regulatory networks: an example. Mol Biol Rep. 2002;29:57-61.
99. Markevich NI, Hoek JB, Kholodenko BN. Signaling switches and bistability arising from multisite phosphorylation in protein kinase cascade. J Cell Biol. 2004;164:353-359.